IACS-9571 hydrochloride is primarily used in research settings to study its potential therapeutic effects, particularly in the field of oncology. It has shown promise as an inhibitor of specific protein-protein interactions, which are critical in cancer cell survival and proliferation. Researchers are exploring its efficacy in targeting and disrupting these interactions, potentially leading to the development of novel cancer treatments. Additionally, it is being investigated for its role in enhancing the effectiveness of existing therapies, such as chemotherapy, by sensitizing cancer cells to treatment. Its application extends to preclinical studies aimed at understanding its mechanism of action and optimizing its pharmacological properties for future clinical use.